Meet Our Team
Senior Experts with Proven Impact
Each of our consultants has 15-25+ years experience in pharma, biotech, or CROs. We have driven multiple programs to IND and market approval- spanning modalities (small molecule, antibodies, ASOs, gene therapies, etc.) and indications (oncology, neurology, rare disease, autoimmune conditions, and more.)
Joseph Kovalchin, PhD
President, Co-founder, Sr. Consultant
Research, Nonclinical Development, Toxicology
Franklin Spriggs, MS
Vice President, Co-founder, Sr. Consultant
Bioanalytical Sciences
Uday Patel, MS, RAC (US, EU)
Sr. Consultant
CMC, Regulatory Affairs
Emma McCullagh, PhD
Vice President, Co-founder, Sr. Consultant
Nonclinical Development, Toxicology, Operations
Gary Wolfe, PhD, DABT (1981-2021)
Sr. Advisor
Toxicology Oversight